Tevogen Bio Holdings - Warrants (14/02/2029)'s operating income is $-21M.
Get informed when a big investor buys or sells
+ FollowAs of Jun 30, 2026
Trailing 12 months ending Jun 30, 2026
As of the most recent data (June 2026), TVGNW shows a operating income of $-21M. That compares with $-31M in the prior-year period — up 31.5% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, TVGNW's operating income is now $-21M (was $-31M) — a 31.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Tevogen Bio Holdings - Warrants (14/02/2029) is outperforming or lagging.
Tracking TVGNW's operating income over time shows whether Tevogen Bio Holdings - Warrants (14/02/2029) is scaling, shrinking, or reshaping that part of the business. The current reading is $-21M That compares with $-31M in the prior-year period — up 31.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this operating income page, Stockcircle has Tevogen Bio Holdings - Warrants (14/02/2029)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-21M) with ownership activity and broader fundamentals.